|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Other income and expenses - net | |||||
| Research and development expenses | |||||
| General and administrative expenses | |||||
| Operating loss | |||||
| Finance income / (costs) - net | |||||
| Loss before tax | |||||
| Income taxes | |||||
| Loss for the period | |||||
| Other comprehensive loss | |||||
| Items that will not be reclassified to profit or loss | |||||
| Equity investments at fair value OCI - net change in fair value | |||||
| Other comprehensive loss | |||||
| Total comprehensive loss | |||||
| Basic and diluted loss per share in per share (undiluted = diluted) | |||||
| Basic loss per share in € per share | |||||
| Diluted loss per share in € per share | |||||
| Weighted number of common shares outstanding | |||||
| Weighted number of common shares outstanding, basic | |||||
| Weighted number of common shares outstanding, diluted |
Loading...
